Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients

This publication has 4 references indexed in Scilit:

• Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine
  AIDS, 2002
• Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
  AIDS, 2001
• Persistent Dyslipidemia in HIV-Infected Individuals Switched From a Protease Inhibitor-Containing to an Efavirenz-Containing Regimen
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
  The Lancet, 1999